MedTrace Logo

The Impact of Small Bowel Obstruction (SBO) on Quality of Life (QOL)

NCT02639195 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2017-02-01

No results posted yet for this study

Summary

This study has two segments the first is a chart and outcome assessment of patients treated at Clear Passage (CP) with a history of small bowel obstruction (SBO). These patients have completed multiple questionnaires as a standard of care for outcome monitoring in the clinic setting, no new data will be collected. The second segment is a prospective observational, online questionnaire based study of subjects with a history of SBO not treated at CP. Data on the impact of quality of life (QOL) over time of subjects not treated at CP will be assessed using the same questionnaire used as standard of care in the clinic twice, 90 days apart. This will be accomplished using the NIH Assessment Center, with subjects able to complete the questionnaires with ease via the internet. As this segment is observational, there is minimal risk to these subjects. The data obtained from the untreated subjects will allow for reporting of overall impact on QOL in this population, data that is not available, as well as provide a control group for assessment of improvement for interventions for SBO.

Conditions

  • Small Bowel Obstruction
  • Quality of Life
  • Bowel Obstruction

Interventions

OTHER

Treatment

Retrospective chart review of patients treated with manual therapy.

Sponsors & Collaborators

  • Clear Passage Therapies, Inc

    lead INDUSTRY

Principal Investigators

  • Amanda Rice, PhD · Clear Passage Therapies

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-04-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02639195 on ClinicalTrials.gov